Models

What is a Model?
32 Models visible to you, out of a total of 49

Mathematica notebook with model simulation of metabolite profiles after 24h incubation with different ratios of HSD11B1 and AKR1C3 transfected HEK293 cells.

Creator: Jacky Snoep

Submitter: Jacky Snoep

Adjusted model to test the model's ability to oxygen consumption rate by permeabilised HepG2 cells in an Oroboros oxygraph. Data from Fletcher et al. (2019).

Creators: Christoff Odendaal, Emmalie Jager, Terry G.J. Derks, Barbara Bakker

Submitter: Christoff Odendaal

Adjusted model to test the model's ability to predict palmitoyl-CoA and octanoyl-CoA dehydrogenation in human liver lysate, with and without anti-MCAD and anti-VLCAD antibodies. Data from Aoyama et al. (1995).

Creators: Christoff Odendaal, Barbara Bakker, Emmalie Jager, Terry G.J. Derks

Submitter: Christoff Odendaal

Unzip model notebooks and keep in the same folder. Notebook names state which notebooks need to be run before them in order for them to word, e.g. "[needs-(1)]" indicates that the notebook numbered 1 must be run and its exported output generated before the given notebook can work. This has to do with the model being generated in only one notebook to avoid duplication.

NLRP3 inflammasome activation

Creators: Julia Somers, Gökçe Yağmur Summak, Ebru Kocakaya

Submitter: Marek Ostaszewski

Thrombotic complications and coagulopathy in COVID-19

Creators: Goar Frischmann, Gisela Fobo, Corinna Montrone

Submitter: Marek Ostaszewski

Kynurenine synthesis pathway

Creators: Julia Somers, Gökçe Yağmur Summak, Ebru Kocakaya

Submitter: Marek Ostaszewski

TGF beta signalling

Creator: Francesco Messina

Submitter: Marek Ostaszewski

The role of the interaction between the SARS-CoV-2 Spike protein and the renin-angiotensin pathway, in particular human ACE2 in pulmonary blood pressure regulation

Creators: Enrico Glaab, Andreas Ruepp, Corinna Montrone, Gisela Fobo

Submitter: Marek Ostaszewski

The Interferon-lambda (IFNL) map describes the action of the drug candidate IFNL on intra- and intercellular signal transduction under SARS-CoV-2.

Creators: Marius Rameil, Vanessa Nakonecnij, Marta Conti

Submitter: Marek Ostaszewski

The relation of the interferon 2 pathway and SARS-CoV-2.

Creators: Anna Niarakis, Vidisha Singh, Sara Sadat AGHAMIRI

Submitter: Marek Ostaszewski

The pathway of heme metabolism under COVID-19, involving Orf3a and Orf9c

Creators: Julia Somers, Emek Demir

Submitter: Marek Ostaszewski

The impact of SARS-CoV-2 on the apoptosis pathway

Creators: Anna Niarakis, Vidisha Singh, Sara Sadat AGHAMIRI

Submitter: Marek Ostaszewski

The pathways focused on SARS-CoV infections curated in Reactome. These pathways are work-in-progress.

Creators: Marc Gillespie, Robin Haw, Peter D'Eustachio

Submitter: Marek Ostaszewski

A diagram of Nsp9 interactions.

Creators: Noriko Hiroi, Yusuke Hiki, Takahiro G. Yamada, Akira Funahashi

Submitter: Marek Ostaszewski

Orf10 of SARS-CoV-2 and its interaction with the Cul2 pathway.

Creators: Jan Hasenauer, Leonard Schmiester, Paul Stapor

Submitter: Marek Ostaszewski

Pyrimidine deprivation and immune response related to human coronavirus infection

Creators: Zsolt Bocskei, Franck Augé, Anna Niarakis

Submitter: Marek Ostaszewski

The mechanisms of the Electron Transport Chain under COVID-19, including Nsp7, Nsp8 and Orf9c

Creator: Julia Scheel

Submitter: Marek Ostaszewski

SARS-CoV-2 impact on the ER stress

Creators: Cristobal Monraz, Inna Kuperstein, Barbara Brauner

Submitter: Marek Ostaszewski

COVID-19 Causal Networks: The SIGNOR team has curated the causal relationships that, according to available evidence, are likely to be relevant for the COVID-19 pathology. The perturbations caused by viral infection are integrated into the cell networks. Evidence obtained using related human coronaviruses diseases such as SARS and MERS are also mapped to the networks. Most of these are indirect relationships as few mechanistic details are clarified to date. As new evidence will be published, it ...

Creators: Luana Licata, Marta Iannuccelli, University of Rome Tor Vergata, IT

Submitter: Marek Ostaszewski

Metabolic interactions of the SARS-CoV-2 Nsp14 with the human galactose, nicotinate and nicotinamide, and purine metabolism.

Creators: Alina Renz, Andreas Dräger

Submitter: Marek Ostaszewski

Interactions of the SARS-CoV-2 E protein with human proteins in the context of histone acetylation.

Creator: Francesco Messina

Submitter: Marek Ostaszewski

Set of pathways encompassing the replication cycle of SARS-CoV-2: attachment, entry, translation, transcription, replication, assembly and release.

Creators: Marcio Acencio, Alexander Mazein

Submitter: Marek Ostaszewski

A diagram of JNK pathway in COVID-19.

Creator: Daniela Börnigen

Submitter: Marek Ostaszewski

A diagram encoding PAMP signaling relevant to COVID-19/SARS-CoV-2

Creator: Matti van Welzen

Submitter: Marek Ostaszewski

Mechanisms related to COVID-19 virus replication cycle, constructed using the mEPN graphical notation.

Creators: Liam Fergusson, Tom Freeman

Submitter: Marek Ostaszewski

RUN the model for steady state.

For the Menadione experiment set the initial concentration of 'Menadione' species to experimental dosing i.e. 100 000 nM (0.1 mM) and make the simulation type "reaction" for both the species i.e. 'Menadione' and 'Menadione_internal'. Then run for 24 hr i.e. 1500 minutes approx. Plot e.g. ATP.

For H2O2 experimental data validation for repeated treatment at 50uM, 150uM, and 300uM. To run the model with different dosing scenarios, one has to set both the H2O2 initial ...

Creators: Alexey Kolodkin, Hans V. Westerhoff, Raju Prasad Sharma

Submitter: Alexey Kolodkin

Executable versions of selected COVID-19 Disease Map diagrams, in SBML-Qual, converted using CaSQ: https://lifeware.inria.fr/~soliman/post/casq/

Creator: Anna Niarakis

Submitter: Marek Ostaszewski

Model building:

The module was built using modular bottom-up approach where every module describes a certain process and then, when modules are connected together like domino tiles, we can reconstruct the emergent behavior of the whole system.

This is a blueprint model and might be used for various country/data. If one wans to use it for a particular country/data, we can recommend following steps:

  1. Adjust total population by changing initial condition of A-Initial_population_innocent_non-tested ...

Creators: Alexey Kolodkin, Hans V. Westerhoff

Submitter: Alexey Kolodkin

A collection of WikiPathways describing various COVID-19 mechanisms.

Creators: Alexander Pico, Chris Evelo, Rex D A B, Egon Willighagen, Lauren J. Dupuis, Matthew Conroy, Friederike Ehrhart, Kristina Hanspers, Amber Koning

Submitter: Marek Ostaszewski

Powered by
(v.1.16.0-pre)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH